The Food and Drug Administration's Oversight of Clinical Investigators' Financial Information (OEI-05-07-00730; 01/09)
Process for collection of financial disclosure by clinical investigators per 21 CFR 54.4 Background: U.S. regulations, 21 CFR 32
SECTION: Research and Compliance NUMBER: CLN-21.00 CHAPTER: Clinical Research Standard Operating Procedures 7/28/2008 REV. A: 5/
![FDA Revised Guidance on Oversight of Clinical Investigators' Financial Information Request for Comment – Policy & Medicine FDA Revised Guidance on Oversight of Clinical Investigators' Financial Information Request for Comment – Policy & Medicine](https://www.policymed.com/wp-content/uploads/2011/06/6a00e5520572bb8834014e88dba2c6970d-800wi.jpg)
FDA Revised Guidance on Oversight of Clinical Investigators' Financial Information Request for Comment – Policy & Medicine
![INVESTIGATOR RESPONSIBILITIES April Objectives Review and Discuss: Responsibilities of the clinical research Investigator as per relevant regulations. - ppt download INVESTIGATOR RESPONSIBILITIES April Objectives Review and Discuss: Responsibilities of the clinical research Investigator as per relevant regulations. - ppt download](https://images.slideplayer.com/37/10694343/slides/slide_25.jpg)